Growing evidence suggests that CRP is also a useful biomarker in oncology and a recent study by Janik and colleagues [13] demonstrated that diagnostic measurement of serum CRP might be useful to identify highly aggressive TETs and to prompt physicians considering tumor recurrences during oncological follow-up. Here, CRP is linked to neoplasm.